YAP activation mediates acquired resistance to ALK inhibitor in ALK rearranged non–small cell lung cancer
Ontology highlight
ABSTRACT: To investigate a possible candidate for overcoming the acquired resistance to ALK-TKI, we established an in vitro model of acquired resistance to crizotinib (H3122-CR) by exposing EML4-ALK–positive H3122 lung cancer cells to increasing doses of crizotinib.
ORGANISM(S): Homo sapiens
PROVIDER: GSE117181 | GEO | 2019/12/31
REPOSITORIES: GEO
ACCESS DATA